Notis Mc Conarty Edward Eli Lilly & CO Transaction History

Notis Mc Conarty Edward

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$592.2 - $792.28 $44,415 - $59,421	-75 Reduced 17.69%	349 $271,000
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $21,532 - $25,384	-41 Reduced 8.82%	424 $247,000
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $4,347 - $5,993	-10 Reduced 2.11%	465 $249,000
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $166,601 - $222,765	475 New	475 $222,000
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $22,508 - $26,226	-70 Reduced 11.29%	550 $201,000
Q3 2022 Nov 08, 2022	SELL	$296.48 - $337.87 $14,824 - $16,893	-50 Reduced 7.46%	620 $201,000
Q2 2022 Jul 19, 2022	SELL	$278.73 - $327.27 $16,723 - $19,636	-60 Reduced 8.22%	670 $217,000
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $164,140 - $203,699	730 New	730 $202,000
Q4 2017 Feb 02, 2018	SELL	$81.94 - $87.89 $245,820 - $263,670	-3,000 Closed	0 $0
Q3 2017 Oct 26, 2017	BUY	$77.07 - $85.54 $231,209 - $256,620	3,000	3,000 $257,000

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Notis Mc Conarty Edward, based on Form 13F filings with the SEC.

Stay updated on Notis Mc Conarty Edward with notifications on news.